PD, M., J, A. Z., I, G., D, D., & T, V. (2025). Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland), 18(9), . https://doi.org/10.3390/ph18091253
Chicago Style (17th ed.) CitationPD, Mingas, Aguiar Zdovc J, Grabnar I, Drobne D, and Vovk T. "Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease." Pharmaceuticals (Basel, Switzerland) 18, no. 9 (2025). https://doi.org/10.3390/ph18091253.
MLA (9th ed.) CitationPD, Mingas, et al. "Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 9, 2025, https://doi.org/10.3390/ph18091253.